The Helmsley Charitable Trust aspires to improve lives by supporting exceptional nonprofits and mission-aligned organizations in the U.S. and around the world in health, place-based initiatives, education and human services.
The Helmsley Charitable Trust supports leading research institutions across the globe in an unprecedented effort to find a cure—and until then better treatments—for IBD and Crohn’s disease. Helmsley has allocated more than $160 million to institutions in the United States, Canada, Europe, and Israel. Many of these projects bring scientists together in new collaborations to study different facets of the disease and incorporate the latest technologies and most recent scientific insights into their explorations. Across the program, nearly 100 Helmsley-funded investigators are working to understand both how human genetics and the gut microbiome can cause and exacerbate IBD and bring those insights into the development of new treatments.https://helmsleytrust.org/